bioRxiv · 10.1101/2023.03.31.535160
Rescue of blood coagulation Factor VIII exon-16 mis-splicing by antisense oligonucleotides
Abstract
The human Factor VIII (F8) protein is essential for the blood coagulation cascade and specific F8 mutations cause the rare bleeding disorder Hemophilia A (HA). Here, we investigated the impact of HA-causing single-nucleotide mutations on F8 pre-mRNA splicing. We found that 14/97 ([~]14.4%) coding sequence mutations tested in our study induced exon skipping. Splicing patterns of 4/11 ([~]36.4%) F8 exons tested were especially sensitive to the presence of common disease-causing mutations. RNA-chemical probing analyses revealed a three-way junction structure at the 3' end of intron 15 (TWJ-3-15). TWJ-3-15 sequesters the polypyrimidine tract, a key determinant of 3' splice site strength. Using exon-16 of the F8 gene as a model, we designed specific antisense oligonucleotides (ASOs) that target TWJ-3-15 and identified three that promote the splicing of F8 exon-16. Interaction of TWJ-3-15 with ASOs increases accessibility of the polypyrimidine tract and inhibits the binding of hnRNPA1-dependent splicing silencing factors. Moreover, ASOs targeting TWJ-3-15 rescue diverse splicing-sensitive HA-causing mutations, most of which are distal to the 3 splice site being impacted. The TWJ-3-15 structure and its effect on mRNA splicing provide a model for HA etiology in patients harboring specific F8 mutations and provide a framework for precision RNA-based HA therapies.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tse, V., Chacaltana, G., Gutierrez, M., Nicholas, F. M., Jimenez, A. G., Tao, H., Do, P. H., Oh, C., Chary, P., Quesada, I., Hamrick, A., Lee, S., Stone, M. D., Sanford, J. R.. 2023-04-01. Rescue of blood coagulation Factor VIII exon-16 mis-splicing by antisense oligonucleotides. https://doi.org/10.1101/2023.03.31.535160
Cite the original work for its findings. Save a collection to share your selection of sources.